Endo Announces $200 Million Settlement for TRT Lawsuits
Endo Announces $200 Million Settlement for TRT Lawsuits
Introduction
Endo International announced a $200 million settlement, thus resolving 1,300 Testosterone product liability cases. The company stated this "master settlement agreement" will conclude "all known" cases and the deal does not include any admission of wrongdoing. The plaintiffs are required to release their claims from a settlement fund where the amount will be deposited by the company.
About 900 testosterone lawsuits are federally-filed against Endo and several other drugmakers for hiding potential risks of TRT. Additional lawsuits are also filed in the Philadelphia Court of Common Pleas and in state courts.
Testosterone Replacement therapy lawsuits were consolidated as a multidistrict litigation (MDL No. 2545 ) in June 2014 before U.S. District Judge Matthew Kennelly in the U.S. District Court for the Northern District of Illinois. All the lawsuits claim similar allegations that the drugmakers falsely marketed the TRT drug and failed to provide adequate warnings to the consumers.
Comments
Latest News
NC to Get $150M to Boost Opioid Treatment, Recovery
Categories: Opioids
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…
SRI Gets FDA OK for High-Dose Naloxone Trial
Categories: Opioids
SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.
The approval was granted under an Investigational New Drug (IND)…
Spokane County to Get $5M in New Opioid Settlement
Categories: Opioids
Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.
The agreement addresses the company’s role in fueling…